Precision medicine is a rapidly growing approach to health care that focuses on finding treatments and interventions that work for people based on their genetic makeup, rather than their symptoms. Zeeshan Ahmed, director of the new Ahmed Lab at Rutgers Institute for Health, Health Care Policy and Aging Research, discusses the future of precision medicine, what needs to be done to successfully analyze the data necessary to develop individualized treatments and the role genetics play during the COVID-19 pandemic. To read the full story.
Recent Posts
- Join Clinical Trials Day at Rutgers on 5/20
- NJ ACTS Success Story – The Kiosk Project
- Doctors Explain How to Tell the Difference Between Cold, Flu, and COVID-19 Symptoms.
- NJACTS Community Engagement Core COVID-19 Resources
- Join NJ ACTS Biostatistics, Epidemiology, Research Design (BERD)on 5/28 at 12pm
Categories
- Community (2,489)
- Covid (1,001)
- CTO Events (6)
- News (3,161)
- Pilots (21)